Anesthetic Efficacy of Gow-Gates Nerve Block, Inferior Alveolar Nerve Block, and Their Combination in Mandibular Molars in Patient with Symptomatic Irreversible Pulpitis

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201705092541N5

Enrollment

150

Registered

2017-07-10

Start date

2017-02-19

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

irriversible pulpitis. Pulpitis: NOS acute chronic (hyperplastic)(ulcerative) irreversible reversible

Interventions

Intervention 1: The patients received two GGNB injections of 1.8 mL 2% lidocaine with 1:180,000 epinephrine. Intervention 2: The patients received two IANB injections of 1.8 mL 2% lidocaine with 1:80,

Treatment - Other

The patients received two GGNB injections of 1.8 mL 2% lidocaine with 1:180,000 epinephrine

The patients received two IANB injections of 1.8 mL 2% lidocaine with 1:80,000 epinephrine

The patients received one GGNB injection plus one IANB injection of 1.8 mL 2% lidocaine with 1:80,000 epinephrine

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Eighteen years of age and over; being in good health condition; having a mandibular first molar tooth with symptomatic irreversible pulpitis; not having severe periodontal problem; normal periapical radiographic appearance (other than a widened periodontal ligament); no history of allergy to local anesthesia or sulfite Exclusion criteria: pregnancy; lactation; taking any medications that might influence anesthetic assessment; swelling or having fistula near target tooth; active sites of pathosis in area of injection; any problem that patient could not give informed consent; lack of lip numbness within 15 minutes after injection

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Initial pain. Timepoint: Before treatment. Method of measurement: Heft-Parker Visual Analog Scale (VAS).	—

Secondary

Measure	Time frame
Post pain. Timepoint: During procedure. Method of measurement: Heft-Parker Visual Analog Scale.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoud Saatchi

Isfahan University of Medical Sciences

saatchi@dnt.mui.ac.ir+98 31 3792 2822

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026